151 related articles for article (PubMed ID: 34907223)
1. Circulating microRNA-197-3p as a potential biomarker for asbestos exposure.
Frontini F; Bononi I; Torreggiani E; Di Mauro G; Mazzoni E; Stendardo M; Boschetto P; Libener R; Guaschino R; Grosso F; Guerra G; Martini F; Tognon M
Sci Rep; 2021 Dec; 11(1):23955. PubMed ID: 34907223
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos.
Di Mauro G; Frontini F; Torreggiani E; Iaquinta MR; Caselli A; Mazziotta C; Esposito V; Mazzoni E; Libener R; Grosso F; Maconi A; Martini F; Bononi I; Tognon M
Sci Rep; 2023 Apr; 13(1):6501. PubMed ID: 37081052
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
[TBL] [Abstract][Full Text] [Related]
5. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
[TBL] [Abstract][Full Text] [Related]
6. Elevated Plasma Levels of Circulating Extracellular miR-320a-3p in Patients with Paroxysmal Atrial Fibrillation.
Zhelankin AV; Vasiliev SV; Stonogina DA; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429037
[TBL] [Abstract][Full Text] [Related]
7. Circulating miRNAs as molecular markers of occupational grain dust exposure.
Straumfors A; Duale N; Foss OAH; Mollerup S
Sci Rep; 2020 Jul; 10(1):11317. PubMed ID: 32647120
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRs-183-5p, -206-3p and -381-3p may serve as novel biomarkers for 4,4'-methylene diphenyl diisocyanate exposure.
Lin CC; Law BF; Siegel PD; Hettick JM
Biomarkers; 2019 Feb; 24(1):76-90. PubMed ID: 30074411
[TBL] [Abstract][Full Text] [Related]
9. Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation.
Filetti V; Falzone L; Rapisarda V; Caltabiano R; Eleonora Graziano AC; Ledda C; Loreto C
Ecotoxicol Environ Saf; 2020 Jul; 198():110640. PubMed ID: 32330788
[TBL] [Abstract][Full Text] [Related]
10. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
[TBL] [Abstract][Full Text] [Related]
13. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability.
Singh S; de Ronde MWJ; Kok MGM; Beijk MA; De Winter RJ; van der Wal AC; Sondermeijer BM; Meijers JCM; Creemers EE; Pinto-Sietsma SJ
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32487772
[TBL] [Abstract][Full Text] [Related]
14. Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
Yamano T; Kubo S; Sonoda E; Kominato T; Kimura K; Yasuhara M; Kataoka K; Son J; Babaya A; Takenaka Y; Matsubara T; Beppu N; Ikeda M
PLoS One; 2021; 16(5):e0250072. PubMed ID: 33945535
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department.
Biener M; Giannitsis E; Thum T; Bär C; Stoyanov KM; Salbach C; de Gonzalo-Calvo D; Frey N; Mueller-Hennessen M
Clin Biochem; 2022 Jan; 99():9-16. PubMed ID: 34571048
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
[TBL] [Abstract][Full Text] [Related]
17. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19).
Fayyad-Kazan M; Makki R; Skafi N; El Homsi M; Hamade A; El Majzoub R; Hamade E; Fayyad-Kazan H; Badran B
Infect Genet Evol; 2021 Oct; 94():105020. PubMed ID: 34343725
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as biomarkers for Sepsis secondary to pneumonia diagnosed via Sepsis 3.0.
Zhang W; Jia J; Liu Z; Si D; Ma L; Zhang G
BMC Pulm Med; 2019 May; 19(1):93. PubMed ID: 31088429
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNAs as Potential Biomarkers for Celiac Disease Development.
Tan IL; Coutinho de Almeida R; Modderman R; Stachurska A; Dekens J; Barisani D; Meijer CR; Roca M; Martinez-Ojinaga E; Shamir R; Auricchio R; Korponay-Szabó IR; Castillejo G; Szajewska H; Koletzko S; Zhernakova A; Kumar V; Li Y; Visschedijk MC; Weersma RK; Troncone R; Mearin ML; Wijmenga C; Jonkers I; Withoff S
Front Immunol; 2021; 12():734763. PubMed ID: 34950132
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA as biomarkers of clozapine-induced cardiotoxicity.
Burns KE; Deane-Alder KD; Bellissima BL; Tingle MD
Biomarkers; 2020 Feb; 25(1):76-85. PubMed ID: 31722571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
